These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158 [TBL] [Abstract][Full Text] [Related]
3. Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? Mato JM; Lu SC Hepatology; 2011 Oct; 54(4):1115-7. PubMed ID: 21898494 [No Abstract] [Full Text] [Related]
4. Evaluation of liver fibrosis: a concise review. Afdhal NH; Nunes D Am J Gastroenterol; 2004 Jun; 99(6):1160-74. PubMed ID: 15180741 [TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease in children: a single center experience. A-Kader HH; Henderson J; Vanhoesen K; Ghishan F; Bhattacharyya A Clin Gastroenterol Hepatol; 2008 Jul; 6(7):799-802. PubMed ID: 18486560 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history? Ong JP; Younossi ZM Am J Gastroenterol; 2003 Sep; 98(9):1915-7. PubMed ID: 14499766 [No Abstract] [Full Text] [Related]
8. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789 [TBL] [Abstract][Full Text] [Related]
10. The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis. Ataseven H; Yildirim MH; Yalniz M; Bahcecioglu IH; Celebi S; Ozercan IH Acta Gastroenterol Belg; 2005; 68(2):221-5. PubMed ID: 16013637 [TBL] [Abstract][Full Text] [Related]
11. [Kidney tumors: clinical and pathological findings and detection]. André M; Hélénon O; De Fromont M; Correas J; Petit P; Bartoli J; Coulange C J Radiol; 2002 Jun; 83(6 Pt 2):773-83, discussion 84-5. PubMed ID: 12218850 [TBL] [Abstract][Full Text] [Related]
12. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771 [TBL] [Abstract][Full Text] [Related]
13. Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. Brandt AS; Kamper L; Kukuk S; Haage P; Roth S J Urol; 2011 Feb; 185(2):526-31. PubMed ID: 21168884 [TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Wieckowska A; Zein NN; Yerian LM; Lopez AR; McCullough AJ; Feldstein AE Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979 [TBL] [Abstract][Full Text] [Related]
15. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers. Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812 [TBL] [Abstract][Full Text] [Related]
16. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Wolf AM; Busch B; Kuhlmann HW; Beisiegel U Obes Surg; 2005 Feb; 15(2):228-37. PubMed ID: 15802066 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients. Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620 [TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis. Akyol G; Erdem O; Yilmaz G Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770 [TBL] [Abstract][Full Text] [Related]
20. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology. Kim TK; Jang HJ; Wilson SR Clin Liver Dis; 2005 May; 9(2):253-79. PubMed ID: 15831272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]